Scarica l'app Stockscreener
340.67
1.50%
-5.19
Dopo l'orario di chiusura:
338.01
-2.66
-0.78%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ELV Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$345.86
Aprire:
$343.69
Volume 24 ore:
1.70M
Relative Volume:
0.95
Capitalizzazione di mercato:
$86.74B
Reddito:
$183.12B
Utile/perdita netta:
$5.92B
Rapporto P/E:
13.29
EPS:
25.63
Flusso di cassa netto:
$3.67B
1 W Prestazione:
-2.06%
1M Prestazione:
-10.57%
6M Prestazione:
-10.62%
1 anno Prestazione:
-36.18%
Intervallo 1D:
$337.61
$344.34
Intervallo di 1 settimana:
$337.61
$350.68
Portata 52W:
$337.61
$567.26
Elevance Health Inc Stock (ELV) Company Profile
Nome
Elevance Health Inc
Settore
Industria
Telefono
(800) 331-1476
Indirizzo
220 VIRGINIA AVENUE, INDIANAPOLIS
Confronta ELV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
340.67 | 86.74B | 183.12B | 5.92B | 3.67B | 25.63 |
|
UNH
Unitedhealth Group Inc
|
304.10 | 275.58B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
303.27 | 82.87B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
64.78 | 81.29B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
230.67 | 28.00B | 117.76B | 1.21B | 2.39B | 9.95 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-15 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | Aggiornamento | Argus | Hold → Buy |
| 2025-01-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | Downgrade | Argus | Buy → Hold |
| 2024-07-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-06-24 | Iniziato | Morgan Stanley | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-06 | Iniziato | Barclays | Overweight |
| 2023-07-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-03-28 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-08-22 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
Mostra tutto
Elevance Health Inc Borsa (ELV) Ultime notizie
Elevance Health, Inc. (NYSE:ELV) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
FINAL ELV DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Elevance Health, Inc. and Urgently Encourages Investors to Contact the Firm - GlobeNewswire
Elevance Health stock hits 52-week low at 339.38 USD - Investing.com
ELV DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Elevance Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 11 Deadline in Securities Class Action – ELV - TradingView
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health - GlobeNewswire
Wells Fargo Maintains a Buy on Elevance Health (ELV), Sets a $478 PT - MSN
Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Bernstein Maintains a Buy on Elevance Health (ELV), Sets a $585 PT - Insider Monkey
Guggenheim Adjusts Price Target on Elevance Health to $447 From $518, Maintains Buy Rating - MarketScreener
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesELV - FinancialContent
ELV COURT NOTICE: Elevance Health, Inc. Investors may have - GlobeNewswire
Elevance Health (ELV): Barclays Lowers Price Target Amid Maintai - GuruFocus
Deadline Soon: Elevance Health, Inc. (ELV) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, and Elevance, and Encourages Investors to Contact the Firm - Morningstar
Elevance Health, Inc. Investors: Please contact the Portnoy - GlobeNewswire
Wells Fargo Maintained a Buy Rating on Elevance Health (ELV), Kept the PT Unchanged - MSN
ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
ELV Shareholders Have the Right to Lead the Elevance Health, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsELV - Morningstar
Elevance Health Insiders Sold US$6.9m Of Shares Suggesting Hesitancy - Yahoo Finance
Insiders At Elevance Health Sold US$6.9m In Stock, Alluding To Potential Weakness - simplywall.st
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health - FinancialContent
ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health - StreetInsider
Deadline Alert: Elevance Health, Inc. (ELV) Investors Who - GlobeNewswire
Is Weakness In Elevance Health, Inc. (NYSE:ELV) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? - Yahoo Finance
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Elevance - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
ELV SHAREHOLDER REPORT: Elevance Health, Inc. was Sued for - GlobeNewswire
INVESTOR ALERT: Berger Montague Advises Elevance Health (ELV) Investors to Inquire About a Securities Fraud Class Action by July 11, 2025 - TradingView
ELV Lead Plaintiff Deadline ApproachingRobbins LLP Reminds Investors to Get Information About Leading the Class Action Against Elevance Health, Inc. - The Malaysian Reserve
Q1 Earnings Outperformers: Elevance Health (NYSE:ELV) And The Rest Of The Health Insurance Providers Stocks - Yahoo Finance
Truist Lowers Elevance Health (ELV) to $500, Keeps Buy Rating - MSN
ELV SHAREHOLDERS: Elevance Health, Inc. Investors are - GlobeNewswire
ELV SHAREHOLDERS: Elevance Health, Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 11 Deadline (NYSE:ELV) - TradingView
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
June 13Parkview Health and Anthem still at odds ahead of contract deadline - Fort Wayne Business Weekly
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance - GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure ... - Eagle-Tribune
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV - TradingView
8 Best Inexpensive Stocks to Buy Right Now - Insider Monkey
ELV CLASS ACTION: Invest in Elevance Health, Inc.? Contact - GlobeNewswire
ELEVANCE HEALTH (ELV) CLASS ACTION NOTICE: Berger Montague Encourages Investors With Substantial Losses to Contact the Firm By July 11, 2025 - TradingView
$1000 Invested In Elevance Health 15 Years Ago Would Be Worth This Much TodayElevance Health (NYSE:ELV) - Benzinga
These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Reasonably Well - Yahoo Finance
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit - GuruFocus
UnitedHealth's Medical Membership Rises: Can It Maintain the Momentum? - The Globe and Mail
Elevance Health (ELV): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Elevance Health (NYSE:ELV) PT Set at $500.00 by Truist Financial - Defense World
Elevance Health Inc Azioni (ELV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.78%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):